![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and...
CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez Kalir to its Board of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.03 | 2.17391304348 | 1.38 | 1.57 | 1.29 | 494796 | 1.43089183 | CS |
4 | -0.22 | -13.4969325153 | 1.63 | 1.6747 | 1.25 | 497837 | 1.39890379 | CS |
12 | 0.48 | 51.6129032258 | 0.93 | 1.8 | 0.7202 | 750072 | 1.22260829 | CS |
26 | 0.54 | 62.0689655172 | 0.87 | 1.8 | 0.63 | 839764 | 1.00813552 | CS |
52 | -0.94 | -40 | 2.35 | 2.43 | 0.63 | 577303 | 1.18549853 | CS |
156 | -6.64 | -82.4844720497 | 8.05 | 9.72 | 0.63 | 284634 | 2.29579965 | CS |
260 | -40.61 | -96.6444550214 | 42.02 | 63.62 | 0.63 | 252368 | 5.97628943 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions